3 completed, 1 active not recruiting, 1 recruiting. 5 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Active not recruiting 1, Recruiting 1 |
| Phase 2 | 5 | Completed 3, Active not recruiting 1, Recruiting 1 |
Follow Neoplasms, Lung: new trials by email Literature Review of Neoplasms, Lung trials Research Report on Neoplasms, Lung
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103) Risvutatug rezetecan, Ivonescimab - Neoplasms, Lung | Phase 1 / Phase 2 | Recruiting | GlaxoSmithKline | 184 | 2026-09-09 | 2026-09-23 |
| Study of ESG401 in Adults With Solid Tumors ESG401 - Neoplasms, Breast, Neoplasms, Lung | Phase 1 / Phase 2 | Completed | Shanghai Escugen Biotechnology Co., Ltd | 156 | 2021-09-14 | 2025-09-12 |
| Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation JDQ443, TNO155, tislelizumab - KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Active not recruiting | Novartis Pharmaceuticals | 344 | 2021-02-24 | 2026-10-19 |
| The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine cancer stem cell vaccine - Neoplasms, Lung | Phase 1 / Phase 2 | Completed | Fuda Cancer Hospital, Guangzhou | 40 | 2014-03-01 | 2019-09-12 |
| Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells cancer stem cell vaccine - Neoplasms, Lung | Phase 1 / Phase 2 | Completed | Fuda Cancer Hospital, Guangzhou | 40 | 2014-03-01 | 2015-06-03 |
Lung Neoplasms (5) · Colorectal Neoplasms (2) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Stomach Neoplasms (1) · Urinary Bladder Neoplasms (1)
Lung Diseases (5) · Neoplasms (5) · Neoplasms by Site (5) · Respiratory Tract Diseases (5) · Respiratory Tract Neoplasms (5) · Thoracic Neoplasms (5) · Colonic Diseases (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Intestinal Diseases (2) · Intestinal Neoplasms (2) · Rectal Diseases (2) · Adnexal Diseases (1)
JDQ443 (1) · tislelizumab (1)
Fuda Cancer Hospital, Guangzhou (2) · GlaxoSmithKline (1) · Novartis Pharmaceuticals (1) · Shanghai Escugen Biotechnology Co., Ltd (1)
China (4) · Japan (2) · United States (2) · Australia (1) · Belgium (1) · Canada (1) · Denmark (1) · France (1) · Germany (1) · Hong Kong (1) · Italy (1) · Netherlands (1) · Singapore (1) · South Korea (1) · Spain (1)
Fei Ma (1)